The clinical prognostic factors that influenced survival and treatment response in our study have grouped themselves in three categories - the components of TNM staging in OS and PFS, tumor progesterone receptor status in RFS and response/TFFs, and the implementation of surgery procedures (regardless of their extent) in treatment response/TFFS analyses. This evidence concerns the gene PGR and neoplasm.